- Round ID
- FR-00472
- Stage
- Equity financing, 1st closing
- Round name
- Equity financing, 1st closing
- Amount
- $142M
Dated funding evidence
OrganOx
Equity financing, 1st closing · $142M · 2025-02-24
Reported round$142MEquity financing, 1st closing
- Disclosure date
- 2025-02-24
- Reported currency
- USD
- Companies House
- 06557113
- Evidence sources
- 2
Company
OrganOxCH 065571132025-02-24Equity financing, 1st closing$142M
Resolved investor records
1 additional source-listed name is retained in the record fields below but not linked without an exact canonical match.
Investor links inherit this round’s named source and date. Resolved links use an exact canonical investor name; unresolved names remain unlinked.
Record fields
What the source states
Amounts, currency, stage and investor names are preserved as reported. No FX conversion, valuation inference or current-holding claim is added.
- Lead investors
- HealthQuest Capital (new)
- Other investors
- Existing: BGF (£20M of this round specifically), Lauxera Capital Partners, University of Oxford, Technikos, Oxford Technology and Innovations Fund, Longwall Ventures. New: Sofina, Soleus Capital, Avidity Partners
- Source layers
- VC research snapshot, Live Chris T D1
- Snapshot
- 2026-10-08
Named evidence
Source trail
This page is published only when the record has a resolved company, disclosure date, round stage and at least one retained source URL.